Evidence map›Paper›PMID 41919095›Full record

ArticleResearch (Washington, D.C.)2026

Multimodal Deep Learning with Routine Clinical Data for Recurrence Risk Stratification in HR

Xiaoyan Wu, Hong Liu, Jingyan Liu, Bing'an Mu, Jianfei Li, Siyu Wang, Fengling Li, Xunxi Lu, Jie Chen, Yulan Peng and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Research (Washington, D.C.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Xiaoyan WuDepartment of Pathology, West China Hospital, Sichuan University, Chengdu, China.ORCID https://orcid.org/https://orcid.org/0000-0003-2300
Hong LiuCollege of Computer Science, Sichuan University, Chengdu, China.
Jingyan LiuDepartment of Medical Ultrasound, West China Hospital, Sichuan University, Chengdu, China.
Bing'an MuCollege of Computer Science, Sichuan University, Chengdu, China.
Jianfei LiCollege of Computer Science and Technology, Chongqing University of Posts and Telecommunications, Chongqing, China.
Siyu WangDepartment of Medical Ultrasound, West China Hospital, Sichuan University, Chengdu, China.
Fengling LiDepartment of Pathology, West China Hospital, Sichuan University, Chengdu, China.
Xunxi LuDepartment of Pathology, West China Hospital, Sichuan University, Chengdu, China.
Jie ChenInstitute of Clinical Pathology, West China Hospital, Sichuan University, Chengdu, China.
Yulan PengDepartment of Medical Ultrasound, West China Hospital, Sichuan University, Chengdu, China.
Yuhao YiInstitute of Clinical Pathology, West China Hospital, Sichuan University, Chengdu, China.
Jiancheng LvCollege of Computer Science, Sichuan University, Chengdu, China.
Hong BuDepartment of Pathology, West China Hospital, Sichuan University, Chengdu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR

Identifiers

PMID41919095
PMCPMC13033830

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.